|
Sep 2026
As of Sep 30, 2026
|
Jun 2026
As of Jun 30, 2026
|
|
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | ||
| Deferred offering costs | ||
| Marketable securities | ||
| Prepaid expenses and other current assets | ||
| Total current assets | ||
| Total assets | ||
| Current liabilities | ||
| Accounts payable | ||
| Accrued expenses | ||
| Warrant liability | ||
| Convertible promissory notes payable, related party | ||
| Total current liabilities | ||
| Total liabilities | ||
| Commitments and contingencies (Note 7) | ||
| Stockholders’ equity (deficit) | ||
| Series A convertible preferred stock, $0.0001 par value; no shares and 15,000,000 shares authorized at September 30, 2026 and December 31, 2025, respectively; 5,661,422 shares issued and outstanding at December 31, 2025 | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares and no shares authorized at September 30, 2026 and December 31, 2025, respectively; no shares issued and outstanding at September 30, 2026 | ||
| Common stock, $0.0001 par value; 500,000,000 and 50,000,000 shares authorized at September 30, 2026 and December 31, 2025, respectively; 14,855,087 and 5,263,158 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | ||
| Additional paid-in capital | ||
| Accumulated deficit | ||
| Total stockholders’ equity (deficit) | ||
| Total liabilities and stockholders’ equity (deficit) |
Loading...